Richard Gaynor
CIK: 0001741284
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jul 1, 2026ZLAB
Zai Lab Ltd
Purchase(P)Direct1.7K shares at avg. $19.05$33K - Jun 17, 2026ZLAB
Zai Lab Ltd
Award(A)Direct22.4K shares- - May 21, 2026ALKS
Alkermes plc.
Exercise(M)Direct6.1K shares- - May 21, 2026ALKS
Alkermes plc.
Tax Payment(F)Direct1.5K shares at avg. $36.95$55K - May 20, 2026ALKS
Alkermes plc.
Award(A)DirectRestricted Stock Unit Award
5.4K shares- - May 20, 2026ALKS
Alkermes plc.
Award(A)DirectNon Qualified Stock Option (Right to Buy)
11.5K shares- - May 20, 2026ALKS
Alkermes plc.
Award(A)DirectNon Qualified Stock Option (Right to Buy)
11.5K shares- - May 20, 2026ALKS
Alkermes plc.
Award(A)DirectRestricted Stock Unit Award
5.4K shares- - Mar 17, 2026ZLAB
Zai Lab Ltd
Purchase(P)Direct1.7K shares at avg. $18.91$33K - Jun 18, 2025ZLAB
Zai Lab Ltd
Award(A)Direct10.8K shares- - May 31, 2025ALKS
Alkermes plc.
Exercise(M)Direct8K shares- - May 31, 2025ALKS
Alkermes plc.
Tax Payment(F)Direct1.9K shares at avg. $30.61$59K - May 21, 2025ALKS
Alkermes plc.
Award(A)DirectRestricted Stock Unit Award
6.1K shares- - May 21, 2025ALKS
Alkermes plc.
Award(A)DirectNon Qualified Stock Option (Right to Buy)
13.5K shares- - Mar 5, 2025ZLAB
Zai Lab Ltd
Sale(S)Direct2.5K shares at avg. $35.07$88K - Sep 3, 2024ZLAB
Zai Lab Ltd
Sale(S)Direct2.5K shares at avg. $19.50$49K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 | ZLAB Zai Lab Ltd | Purchase(P) | 1,736 | $19.05 | $33,071 | Direct |
| Jun 17, 2026 | ZLAB Zai Lab Ltd | Award(A) | 22,371 | - | $0 | Direct |
| May 21, 2026 | ALKS Alkermes plc. | Exercise(M) | 6,142 | - | $0 | Direct |
| May 21, 2026 | ALKS Alkermes plc. | Tax Payment(F) | 1,475 | $36.95 | $54,501 | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award(A) Restricted Stock Unit Award | 5,409 | - | - | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award(A) Non Qualified Stock Option (Right to Buy) | 11,538 | - | - | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award(A) Non Qualified Stock Option (Right to Buy) | 11,538 | - | - | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award(A) Restricted Stock Unit Award | 5,409 | - | - | Direct |
| Mar 17, 2026 | ZLAB Zai Lab Ltd | Purchase(P) | 1,731 | $18.91 | $32,733 | Direct |
| Jun 18, 2025 | ZLAB Zai Lab Ltd | Award(A) | 10,831 | - | - | Direct |
| May 31, 2025 | ALKS Alkermes plc. | Exercise(M) | 8,013 | - | - | Direct |
| May 31, 2025 | ALKS Alkermes plc. | Tax Payment(F) | 1,924 | $30.61 | $58,894 | Direct |
| May 21, 2025 | ALKS Alkermes plc. | Award(A) Restricted Stock Unit Award | 6,142 | - | - | Direct |
| May 21, 2025 | ALKS Alkermes plc. | Award(A) Non Qualified Stock Option (Right to Buy) | 13,474 | - | - | Direct |
| Mar 5, 2025 | ZLAB Zai Lab Ltd | Sale(S) | 2,500 | $35.07 | $87,675 | Direct |
| Sep 3, 2024 | ZLAB Zai Lab Ltd | Sale(S) | 2,500 | $19.50 | $48,750 | Direct |
1-16 of 16 transactions
About GAYNOR RICHARD
GAYNOR RICHARD (SEC CIK 0001741284) files insider reports with the SEC as Director of Zai Lab Ltd (ZLAB) and Director of Alkermes plc. (ALKS).
Signal8 holds 10 ownership filings by GAYNOR RICHARD, all Form 4s, filed between Sep 5, 2024 and Jul 6, 2026. Those filings report 16 transactions, from Sep 3, 2024 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GAYNOR RICHARD's filings is in CAMBRIDGE, MA.
Recent filings by GAYNOR RICHARD
- Jul 1, 2026: Open-market purchase of ZLAB shares (Form 4, code P).
- Jun 17, 2026: Grant or award of ZLAB shares (Form 4, code A).
- May 21, 2026: Option exercise of ALKS shares (Form 4, code M).
- May 21, 2026: Tax withholding of ALKS shares (Form 4, code F).
- May 20, 2026: Grants or awards of ALKS derivative securities (4 lines, Form 4, code A).
Other insiders filing for Zai Lab Ltd (ZLAB)
- Chen Yajing, Chief Financial Officer
- Lis William, Director
- Du Ying, Chairperson & CEO
- Edmondson Frazor Titus III, Chief Legal Officer
- Morrison Scott W, Director
- Vounatsos Michel, Director